Phase I evaluation of lenvatinib and weekly paclitaxel in patients with recurrent endometrial, ovarian, fallopian tube, or primary peritoneal Cancer

Floor Backes, Lai Wei, Min Chen, Kasey Hill, Kyle Dzwigalski, Ming Poi, Mitch A. Phelps, Ritu Salani, Larry J. Copeland, Jeffrey M. Fowler, David E. Cohn, Kristin Bixel, Casey Cosgrove, John L. Hays, David M. O’Malley